Hide Board Information

Show Board Information

CytoDyn Inc CYDY

Board Mod: HHIGambler

Asst Mods: Riztheinvestor CaptnAmerca mightycydy

Last Post: 12/26/2024 4:55:39 PM

Board Marks: 388

Posts Today: 0

Board Views Today: 29215

CytoDyn Inc. (OTCQB: CYDY)

Company Website: http://www.cytodyn.com/

CytoDyn Inc (OTCMRKTS: CYDY) Stock Message Board

1. CYDY Company Profile

    

2. CYDY Time & Sales

    

3. CYDY Recent News

    

4. CYDY Filings

    

5. CYDY Financials

    

6. CYDY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

13623	Leronlimab (Pro 140) Cliff Notes What is it? (37)	trding	12/24/2019 8:09:27 PM
112006	Leronlimab - Disease List (currently 90) (updated (28)	ohm20	12/09/2021 8:15:12 AM
144440	Leronlimab Regulator List (a work in progress) = (18)	ohm20	06/12/2024 7:33:56 PM
145805	Here's some basics on the science - Leronlimab (44)	ohm20	08/21/2024 12:48:53 PM
72072	Heres something the Mods rarely if ever hear. (2)	BronxBoy	01/10/2021 9:40:48 AM
72070	gestalt, You are likely correct that there will (6)	CTMedic	01/10/2021 9:09:11 AM
72068	Good point, I dont think there will be any (10)	gestalt2	01/10/2021 7:52:32 AM
72067	COVID numbers are increasing in the UK as well (3)	Boatbuilder	01/10/2021 7:07:15 AM
72066	The CD12 results will be good, no doubt...much (3)	Werner	01/10/2021 5:27:31 AM
72065	Don't get ahead of yourself. Tuesday, January (11)	MarcS	01/10/2021 3:09:49 AM
72064	CYDY Investors Hangout Folks Regarding sean007's (2)	calstang	01/10/2021 2:40:42 AM
72063	Maybe our perspective/expectations should be that	calstang	01/10/2021 2:31:14 AM
72062	Calstang, I believe there is still a lot to do	mtruong34	01/10/2021 2:26:09 AM
72061	Research Letter Open Access Published: 04 January (3)	mtruong34	01/10/2021 2:22:59 AM
72060	Tuesday Jan 12th data s/c unblinded. We expect an (2)	calstang	01/10/2021 2:22:04 AM
72058	The MAJOR difference between us and any John	sean007	01/10/2021 1:27:57 AM
72057	Thanks for pointing that out is they can quickly	onestepahead	01/10/2021 1:24:05 AM
72056	Thanks for sharing this post from YMB. One of the (1)	ClosetInvestor	01/10/2021 12:05:40 AM
72055	Thank you very much I am glad someone was paying (1)	Longestyard	01/09/2021 11:40:04 PM
72054	My example was for cd12 s/c 50% interim. Since it	mtruong34	01/09/2021 11:19:22 PM
72053	The statement would be out out by the PR (4)	ClosetInvestor	01/09/2021 11:03:07 PM
72052	Following was posted by Science + Compliance on (13)	Enjay	01/09/2021 11:00:23 PM
72050	Yep...like that press GLTA	Shelly2626	01/09/2021 9:23:45 PM
72049	I disagree. The statement would be out out by the	jeff67	01/09/2021 9:10:42 PM
72048	It goes without saying that Leronlimab will blow (1)	Hanman	01/09/2021 8:47:17 PM
72047	Welcome to the board arbo99. Nice first post	SeeWhyDY	01/09/2021 8:27:47 PM
72046	I understand your frustration, several years ago (1)	biloxiblues	01/09/2021 8:27:29 PM
72043	I would put out a press release early. I would (10)	ClosetInvestor	01/09/2021 7:29:11 PM
72042	Thanks Closetinvestor! I'm on here daily, but (19)	NuGilead	01/09/2021 7:25:10 PM
72041	Remember after the press hype about the two most	MD VIROLOGIST	01/09/2021 7:17:55 PM
72039	If I were Cytodyn exec management team , once I (1)	jeff67	01/09/2021 6:49:44 PM
72037	They were working as quick as they could for mild	onestepahead	01/09/2021 6:36:55 PM
72036	NuGilead was here posting long before you ever (1)	ClosetInvestor	01/09/2021 6:33:25 PM
72035	NuGilead. Thanks for the informative post. (1)	ClosetInvestor	01/09/2021 6:32:13 PM
72034	11 more days	CDiddy	01/09/2021 6:30:14 PM
72033	Probably not worth speculating on since we'll	cardamine	01/09/2021 6:27:48 PM
72032	You are setting unrealistic expectations if you (2)	mtruong34	01/09/2021 6:14:25 PM
72031	You are spot on especially # 4. Part of the (1)	MD VIROLOGIST	01/09/2021 6:03:24 PM
72030	Agree the real heros of the story are the ones (2)	Riztheinvestor	01/09/2021 5:57:41 PM
72029	M.F. being a hero, Ll didn't show any SAEs in	123kidc	01/09/2021 5:56:54 PM
72026	There was no 75% interim analysis. Because of the	MarcS	01/09/2021 5:15:42 PM
72025	I'm guessing he was in the placebo	CDiddy	01/09/2021 4:27:27 PM
72022	Excellent work NuGilead on the timelines! Also (3)	mtruong34	01/09/2021 3:24:41 PM
72021	Bravo! Those sentiments have been rattling around (3)	PennySlayer	01/09/2021 3:16:38 PM
72020	It would seem to be at least more than a day, but	MarcS	01/09/2021 3:01:53 PM
72019	It was a long process (but not abmormal), not the (21)	NuGilead	01/09/2021 2:49:26 PM
72017	A clue would be if he died before or after 3 (1)	nmbr1stckpckr	01/09/2021 2:31:35 PM
72016	I hope when this all shakes out, that the (4)	cardamine	01/09/2021 2:31:14 PM
72015	There has to be initial analytics applied after (1)	MD VIROLOGIST	01/09/2021 2:30:21 PM
72014	Did anyone pay close attention to the mm	Longestyard	01/09/2021 1:08:20 PM
72013	Barbaric practice. And I certainly hope that (7)	Boatbuilder	01/09/2021 12:54:39 PM
72012	It's heartbreaking that we have to prove the (10)	CDiddy	01/09/2021 12:44:01 PM
72011	The heroes are the ones who took part in the (28)	MarcS	01/09/2021 12:40:07 PM
72010	Calstang, was intended on my part as a reaction (2)	WUM	01/09/2021 12:37:26 PM

Newer

Older

Recent Articles

• Understanding Your Rights in the Dentsply Class Action Lawsuit
• Navigating the Class Action Lawsuit for ASP Isotopes Inc.
• Celsius Holdings Faces Class Action: What Investors Need to Know
• Cassava Sciences Faces Lawsuit Amid Securities Fraud Claims
• Class Action Alert for Hasbro, Inc. Investors – Take Action Now
• Norsk Hydro Share Buyback Program Update and Insights
• Legal Proceedings for Five9, Inc. Shareholders: Key Information
• Symbotic Inc. Faces Class Action Lawsuit – Investor Deadline Looms
• Join the PACS Group, Inc. Class Action for Shareholder Support
• Marqeta, Inc. Shareholders Alert: Class Action Lawsuit Update
• Securities Class Action Filed for Lilium N.V. Shareholders
• FDA Approves TEVIMBRA for Advanced Gastric Cancer Treatment
• Important Update for Humacyte, Inc. Shareholders on Legal Action
• Important Investor Update for Xerox Holdings Corporation - XRX
• Visa Inc. Shareholders: Important Class Action Lawsuit Update
• Lilium N.V. Shareholders Targeted in Securities Class Action Lawsuit
• Investors of Evolv Technologies Holdings, Inc. Take Action Now
• Explore Your Rights as a Warner Bros. Discovery Investor
• Sun Communities Faces Class Action Over Alleged Securities Fraud
• Join MGP Ingredients Class Action: Claim Your Rights Today
• Major Legal Action Against Rentokil Initial plc: What Investors Need to Know
• Investors Alert: Action Against Zeta Global Holdings Corp. Gains Momentum
• Roundhill Investments Reveals Latest ETF Dividends for December
• IDEAYA Biosciences Reveals New Equity Award Grant Strategy
• Burford Capital Ltd Issues New Shares to Support LTIP Program
• Yaber Celebrates Exceptional Sales Growth and Future Innovation
• Ukraine's Humanitarian Initiative: Wheat Aid to Syria
• CPIC Life Welcomes ZHAO Yonggang as New Chairman of Board
• Ithaca Energy Executives Enhance Stake Through Incentives
• Goldman Sachs Predicts Continuing Economic Challenges Ahead
• Wall Street Futures Take a Dip as Year-End Rally Faces Pressure
• Trends in U.S. Equity Flows: A Pre-Christmas Reflection
• Financial Events of 2024 That Will Impact 2025 Strategies
• Elon Musk Highlights Wernher Von Braun's Impact on Space Exploration
• Join the Fight: Class Action Against Customers Bancorp, Inc.
• Wolfspeed Investors Urged to Act in Class Action Lawsuit
• Volatility in European Gas Prices Amid Geopolitical Tensions
• Toyota Finance Australia Reveals Latest Semi-Annual Report Data
• Germany's Political Landscape Shifts with Early Election Announcement
• Equity Market Turmoil: U.S. Funds Experience Major Outflows
• Positive Closing for Indian Stocks: Key Players and Trends
• AMD and NVIDIA: Analyzing Semiconductor Investments Ahead
• M2's Vision for Digital Assets: Pioneering Innovations Ahead
• Discover Boost Lottery's Innovative Global Lottery Launch
• Forecast of Japan's Mainframe Market Surpassing $365 Million
• Innovative Child Presence Detection Systems Set to Transform Market
• Exploring the Booming Bioplastics Industry: Future Insights
• Investor Confidence Rises Again as Global Equity Funds Soar
• U.S. Equity Funds See Major Inflows Amid Holiday Optimism
• Delivery Hero Faces Challenges Following Taiwan's Block on Uber Deal